ArticleBreast cancer research and treatment2023

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry.

Khava I E Ibragimova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.